Pleuropulmonary blastoma: A marker for familial disease
John R. Priest(Massachusetts General Hospital), Louis P. Dehner(Jewish Hospital), Julio C. Barredo(University of Miami), Irene Newsham(University of Minnesota), Vicki Huff(The University of Texas MD Anderson Cancer Center), Alberto S. Pappo(St. Jude Children's Research Hospital), Gloria Kohut, Louise C. Strong(University of Minnesota), Stephen Friend(University of Oxford), Jan Watterson(University of Minnesota), Mary S. Richardson(University of Minnesota), David R. Freyer(University of Southern California), Claire Langston(Baylor College of Medicine), Donald H. Mahoney(University of Minnesota), Michael D. Amylon(University of Minnesota), Ruth Heyn(University of Minnesota), Bruce Bostrom(Children's Hospital of Los Angeles), William G. Woods(University of Minnesota), Rebecca Byrd(University of Minnesota)
Cited by 230
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
|Nature Genetics|1998|646
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|433